Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 44.49 is 23% above its 5-year average of 36.04, near the high end of its 5-year range (25.24–44.49).
7.41% above its 12-month average of 41.42.
Reported quarterly EPS; no daily interpolation.
EPS growth vs the same quarter one year earlier, last 40 quarters.
EARNINGS PER SHARE (EPS)
44.49
EARNINGS PER SHARE (EPS) AVG TTM
41.42
EARNINGS PER SHARE (EPS) AVG 3Y
39.43
EARNINGS PER SHARE (EPS) AVG 5Y
36.04
EARNINGS PER SHARE (EPS) AVG 10Y
27.39
EARNINGS PER SHARE (EPS) AVG 15Y
21.75
EARNINGS PER SHARE (EPS) AVG 20Y
17.64
CURRENT VS TTM AVG
+7.41%
CURRENT VS 3Y AVG
+12.83%
CURRENT VS 5Y AVG
+23.46%
CURRENT VS 10Y AVG
+62.45%
CURRENT VS 15Y AVG
+104.56%
CURRENT VS 20Y AVG
+152.27%
Mettler-Toledo International Inc.
Market Cap
$26.87B
Earnings Per Share (EPS)
44.49
TTM Avg
41.42
3Y Avg
39.43
5Y Avg
36.04
Market Cap
$26.79B
Earnings Per Share (EPS)
12.09
TTM Avg
9.71
3Y Avg
9.57
5Y Avg
13.14
Market Cap
$26.18B
Earnings Per Share (EPS)
9.42
TTM Avg
8.33
3Y Avg
8.09
5Y Avg
9.83
Market Cap
$25.60B
Earnings Per Share (EPS)
7.85
TTM Avg
3.38
3Y Avg
2.74
5Y Avg
2.31
Market Cap
$24.90B
Earnings Per Share (EPS)
-7.76
TTM Avg
-4.08
3Y Avg
9.21
5Y Avg
14.48
Market Cap
$23.86B
Earnings Per Share (EPS)
7.82
TTM Avg
6.79
3Y Avg
7.36
5Y Avg
7.17
Market Cap
$30.29B
Earnings Per Share (EPS)
4.01
TTM Avg
10.78
3Y Avg
11.05
5Y Avg
10.65
Market Cap
$30.35B
Earnings Per Share (EPS)
3.45
TTM Avg
4.46
3Y Avg
4.05
5Y Avg
4.25
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mettler-Toledo International Inc. (MTD) | $26.87B | 44.49 | 41.42 | 39.43 | 36.04 |
| Labcorp Holdings Inc. (LH)vs › | $26.79B | 12.09 | 9.71 | 9.57 | 13.14 |
| Quest Diagnostics Incorporated (DGX)vs › | $26.18B | 9.42 | 8.33 | 8.09 | 9.83 |
| Incyte Corporation (INCY)vs › | $25.60B | 7.85 | 3.38 | 2.74 | 2.31 |
| BioNTech SE (BNTX)vs › | $24.90B | -7.76 | -4.08 | 9.21 | 14.48 |
| Medline Inc. (MDLN)vs › | $29.69B | 0.86 | 1.48 | 0.80 | 0.80 |
| West Pharmaceutical Services, Inc. (WST)vs › | $23.86B | 7.82 | 6.79 | 7.36 | 7.17 |
| Waters Corporation (WAT)vs › | $30.29B | 4.01 | 10.78 | 11.05 | 10.65 |
| GE HealthCare Technologies Inc. (GEHC)vs › | $30.35B | 3.45 | 4.46 | 4.05 | 4.25 |
| Zoetis Inc. (ZTS)vs › | $31.07B | 6.07 | 5.75 | 5.27 | 4.80 |
Trailing EPS (TTM)
$44.49
Forward EPS (Est.)
$47.33
P/E Ratio
30.2
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 42.17 |
| 2024-12-31 | 40.67 |
| 2023-12-31 | 36.10 |
| 2022-12-31 | 38.79 |
| 2021-12-31 | 33.25 |
| 2020-12-31 | 25.24 |
| 2019-12-31 | 22.84 |
| 2018-12-31 | 20.33 |
| 2017-12-31 | 14.62 |
| 2016-12-31 | 14.49 |
| 2015-12-31 | 12.75 |
| 2014-12-31 | 11.71 |
| 2013-12-31 | 10.22 |
| 2012-12-31 | 9.37 |
| 2011-12-31 | 8.45 |
| 2010-12-31 | 6.98 |
| 2009-12-31 | 5.12 |
| 2008-12-31 | 5.92 |
| 2007-12-31 | 4.82 |
| 2006-12-31 | 3.93 |
| 2005-12-31 | 2.58 |
| 2004-12-31 | 2.44 |
| 2003-12-31 | 2.15 |
| 2002-12-31 | 2.27 |
| 2001-12-31 | 1.78 |
| 2000-12-31 | 1.80 |
| 1999-12-31 | 1.25 |
| 1998-12-31 | 0.98 |
| 1997-12-31 | -2.08 |
Reported annual fiscal-period values; no daily interpolation.